Immediate Impact
81 standout
Citing Papers
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Translating p53-based therapies for cancer into the clinic
2024 Standout
Works of Nicholas Vitale being referenced
Abstract 43: Discovery of ARV-110, a first in class androgen receptor degrading PROTAC for the treatment of men with metastatic castration resistant prostate cancer
2021
ARV-110: An oral androgen receptor PROTAC degrader for prostate cancer.
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nicholas Vitale | 280 | 38 | 132 | 87 | 9 | 317 | |
| Dmitry Baturin | 244 | 17 | 122 | 57 | 10 | 301 | |
| Christina D. Drenberg | 196 | 26 | 81 | 102 | 11 | 287 | |
| Marsha Jones | 162 | 21 | 59 | 43 | 11 | 338 | |
| Magda Melchert | 167 | 18 | 39 | 178 | 8 | 323 | |
| W. S. Dalton | 171 | 10 | 211 | 40 | 6 | 322 | |
| Stephen M. Hart | 241 | 12 | 122 | 57 | 10 | 365 | |
| Juanita Garrison | 165 | 8 | 132 | 51 | 6 | 356 | |
| Shalina Gupta-Burt | 141 | 30 | 191 | 17 | 10 | 298 | |
| C. Norman Coleman | 140 | 46 | 125 | 20 | 7 | 295 | |
| Alexey Moisseev | 137 | 57 | 119 | 21 | 11 | 275 |
All Works
Login with ORCID to disown or claim papers
Loading papers...